Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Marty

Showing results (381-390 of 391) with videos related to

Pageof 40
Sort By:
The New England Journal of Medicine|December 7, 2017
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationFrancisco M Marty, Per Ljungman, Roy F Chemaly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2008
Persistent and relapsing babesiosis in immunocompromised patientsPeter J Krause, Benjamin E Gewurz, David Hill, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2012
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerD Farge, P Debourdeau, M Beckers, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2012
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancerP Debourdeau, D Farge, M Beckers, et al.
The New England Journal of Medicine|August 9, 2013
Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndromeAmi S Bhatt, Samuel S Freeman, Alex F Herrera, et al.
The New England Journal of Medicine|May 28, 2020
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19Jason D Goldman, David C B Lye, David S Hui, et al.
The New England Journal of Medicine|December 22, 2021
Early Remdesivir to Prevent Progression to Severe Covid-19 in OutpatientsRobert L Gottlieb, Carlos E Vaca, Roger Paredes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2019
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant RecipientsRoy F Chemaly, Sanjeet S Dadwal, Anne Bergeron, et al.
JAMA|August 22, 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical TrialChristoph D Spinner, Robert L Gottlieb, Gerard J Criner, et al.
The New England Journal of Medicine|May 26, 2006
Transmission of lymphocytic choriomeningitis virus by organ transplantationStaci A Fischer, Mary Beth Graham, Matthew J Kuehnert, et al.
Pageof 40

Showing results (381-390 of 391) with videos related to

Sort By:
Pageof 40
The New England Journal of Medicine|December 7, 2017
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationFrancisco M Marty, Per Ljungman, Roy F Chemaly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2008
Persistent and relapsing babesiosis in immunocompromised patientsPeter J Krause, Benjamin E Gewurz, David Hill, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2012
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerD Farge, P Debourdeau, M Beckers, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2012
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancerP Debourdeau, D Farge, M Beckers, et al.
The New England Journal of Medicine|August 9, 2013
Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndromeAmi S Bhatt, Samuel S Freeman, Alex F Herrera, et al.
The New England Journal of Medicine|May 28, 2020
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19Jason D Goldman, David C B Lye, David S Hui, et al.
The New England Journal of Medicine|December 22, 2021
Early Remdesivir to Prevent Progression to Severe Covid-19 in OutpatientsRobert L Gottlieb, Carlos E Vaca, Roger Paredes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2019
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant RecipientsRoy F Chemaly, Sanjeet S Dadwal, Anne Bergeron, et al.
JAMA|August 22, 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical TrialChristoph D Spinner, Robert L Gottlieb, Gerard J Criner, et al.
The New England Journal of Medicine|May 26, 2006
Transmission of lymphocytic choriomeningitis virus by organ transplantationStaci A Fischer, Mary Beth Graham, Matthew J Kuehnert, et al.
Pageof 40